O-Glycan Truncation Promotes Melanogenesis in Cultured Cells
October 16, 2026
Experiments in cultured pigment-producing cells show that shortening O-glycans can increase melanin production. The findings also raise a more specific question: how does glycan remodeling affect proteins involved in endoplasmic reticulum homeostasis?
Introduction
Skin pigmentation is governed by melanogenesis, a tightly regulated pathway centered on the enzyme tyrosinase and the transcription factor MITF. A Scientific Reports study examines how O-glycan truncation affects melanin synthesis in cultured melanoma cells and melanocytes. The findings implicate the chloride channel CLCC1 as a candidate regulator, while leaving its glycosylation-dependent mechanism to be resolved.
The authors began with lectin-based glycomic profiling, comparing highly pigmented melanoma cells and primary melanocytes with their lightly pigmented counterparts. The readout that separated the groups was the peanut agglutinin (PNA) signal, which detects exposed core 1 O-glycan motifs, including Galβ1-3GalNAcα-O-Ser/Thr. Increased PNA binding is consistent with greater exposure of these motifs, but does not alone resolve the complete glycan structures. Complementary O-Glycan Profiling can help characterize the changes suggested by lectin staining.
Truncated O-Glycans Track With High Melanin
Across seven melanoma lines and three primary melanocyte cultures used for the initial profiling, higher pigmentation was associated with stronger PNA reactivity. MNT-1 cells showed stronger PNA staining than the low-pigmented SK-MEL-28 and A375 cells, and the primary melanocyte cultures showed a similar pattern. The authors measured lower C2GnT1 mRNA expression in highly pigmented cells; C2GnT1 knockdown increased PNA binding and melanin production. Separately, treatment with the O-glycosylation inhibitor benzyl N-acetyl-α-D-galactosaminide (BAG) increased PNA binding and pigmentation. BAG was not shown to be a selective C2GnT1 inhibitor.

Fig. 1 Lectin-based glycomic profiling reveals O-glycan truncation enriched in highly pigmented cells. (Teeravirote, et al., 2026)
From Glycans to the Proteome
To identify candidate proteins, the team combined global proteomics with PNA affinity-enriched glycoproteomics. Global analysis identified 8,202 proteins, of which 759 were significantly upregulated after BAG treatment. The lectin-enriched analysis identified 422 HexNAc(1)Hex(1)-modified glycopeptides with increased abundance. Among the candidates, CLCC1 stood out as a plausible regulator of melanogenesis.
This integration of lectin capture with mass spectrometry is an application of Lectin-based Technologies for Glycan Profiling. Complementary Lectin Microarray Assay screening could help compare glycan-binding patterns in future studies; the paper itself used lectin fluorescence staining and PNA affinity enrichment, rather than a lectin microarray.
CLCC1 Links O-Glycosylation With ER Homeostasis
CLCC1 is a chloride channel implicated in endoplasmic reticulum function. The authors found that CLCC1 knockdown enhanced melanin production and increased calnexin expression and reactive oxygen species. BAG treatment increased PNA-reactive CLCC1 without a significant change in total CLCC1 protein abundance, alongside increased calnexin and ROS signals. These findings support a proposed link between CLCC1 glycosylation, ER homeostasis, and melanogenesis, but BAG affects multiple glycoproteins and does not isolate a CLCC1-specific mechanism.

Fig. 2 Integrated proteomic and PNA-enriched glycoproteomic analysis identifies CLCC1 as a candidate associated with O-glycan remodeling. (Teeravirote, et al., 2026)
Implications for Pigmentation Disorders
The findings suggest that O-glycan remodeling deserves further investigation in pigmentation biology. The study did not test a treatment for pigmentation disorders, and increased calnexin and ROS signals do not establish every step of an ER stress-mediated pathway. Selective manipulation of glycan elongation and candidate glycoproteins would help test the proposed mechanism.
Validating such targets requires complementary glycan and protein measurements. Glycomic Characterization Service and Glycoprotein Structure Analysis can inform this work, with site-resolved glycoproteomics needed when individual modification sites are the question. In this study, the CLCC1 glycopeptide assignment did not confidently distinguish T530 from S532.
The C2GnT1 Elongation Axis in Molecular Detail
C2GnT1 adds GlcNAc in a β1,6 linkage to the GalNAc of core 1, forming the core 2 branch. This is one route of O-glycan elaboration, rather than a requirement for all extended O-glycans. Lower C2GnT1 mRNA expression was associated with higher pigmentation in the compared cell lines, and its knockdown increased PNA binding and melanin production. These experiments support a role for C2GnT1-dependent remodeling without establishing the glycan length of every affected protein.
Core 2 branching provides a route for further glycan elaboration, but changes in PNA binding do not quantify every truncated and extended glycoform. Likewise, the global proteomic response to BAG cannot be attributed solely to loss of C2GnT1 activity. Comparing glycopeptide changes with total protein abundance helps distinguish altered glycosylation from changes in the amount of the carrier protein, as illustrated by CLCC1.
From Cell Lines to Physiological Melanocytes
Much of the evidence came from melanoma lines, which are convenient but can carry glycosylation aberrations unrelated to normal pigmentation. The inclusion of primary melanocytes extends the pigmentation-associated PNA pattern beyond melanoma lines, but does not by itself validate the CLCC1 mechanism in normal skin. Still, primary cultures are not the whole organism. Validating the CLCC1 mechanism in three-dimensional skin models or ex vivo tissue would strengthen the assessment of physiological relevance.
There is also the question of directionality. The study provides intervention evidence for C2GnT1 knockdown, BAG treatment, and CLCC1 knockdown, but does not isolate the effect of changing CLCC1 glycan structure at a single site. The authors note that the modification could not be confidently assigned between T530 and S532. Site-directed mutagenesis could test site occupancy, while CLCC1-specific rescue combined with glycan elongation experiments would be needed to distinguish loss of a glycan from its truncation.
The pigmentation-associated PNA pattern is a research observation, rather than a validated diagnostic readout. Skin or serum biomarker performance and treatment-monitoring utility were not tested. Any such application would require independent validation of sample specificity, reproducibility, and its relationship to melanogenic activity.
Outlook
CLCC1 is a candidate for further mechanistic study. Its contribution relative to other BAG-responsive glycoproteins remains unresolved, and validation in normal melanocytes and physiological models is needed. The work supports a role for O-glycan remodeling in melanogenesis in the tested cultures, while leaving the CLCC1-specific causal pathway open.
For glycoscience, the paper illustrates how lectin-guided glycoproteomics can connect a glycan-associated phenotype with candidate enzymes and proteins. It also shows why glycan composition, site localization, protein abundance, and functional validation need to be considered separately.
Related Services & Products
Reference
- Teeravirote, K., et al. (2026). Lectin-based glycoproteomics reveals a novel role of O-glycan truncation in the induction of melanogenesis. Scientific Reports. DOI: 10.1038/s41598-026-69010-7.